Covered stent versus bare-metal stents for chronic total occluded long complicated femoropopliteal lesions: A 2-year single center review

Ting Chao Lin, Po Lin Chen, Chiu Yang Lee, Chun Che Shih, I. Ming Chen

研究成果: 雜誌貢獻文章

摘要

BACKGROUND: To compare the efficacy, safety, and results of Viabahn versus bare-metal stents (BMS) in chronic total occluded (CTO) long femoropopliteal lesions. METHODS: From April 2009 to August 2014, a total 97 patients (71.2 ± 9.7, 45-90 years old, 70 males) with occluded femo-ropopliteal lesions underwent Viabahn (55 patients) or BMS (42 patients) implantation. The clinical findings, procedural factors, and overall outcomes were collected and analyzed. RESULTS: The average lesion length was 22.1 ± 4.8 cm in the Viabahn group and 17.8 ± 3.3 cm in the BMS group. Both groups had a 100% technical success rate. Although there was no difference between the groups in complication, mortality, and major amputation rates, the Viabahn group had a significantly better average post-operative ankle brachial index (ABI) at 1-year and 2-year follow-ups. The Viabahn group also had significantly less in-stent restenosis (ISR) and target lesion revascularization (TLR) compared with the BMS group. Nevertheless, the two groups shared similar 2-year primary patency rates (63.6% vs. 50.0%, p = .178) and 2-year secondary patency rates (85.5% vs. 81.0%, p = .554). CONCLUSION: Both Viabahn and BMS were efficient treatments for long femoropopliteal CTO lesions. However, the Viabahn group had significantly improved results compared with the BMS group in TLR and ISR, but the difference was not sufficient enough to result in different primary and secondary patency rates.
原文英語
頁(從 - 到)44-49
頁數6
期刊Journal of the Chinese Medical Association : JCMA
82
發行號1
DOIs
出版狀態已發佈 - 一月 1 2019
對外發佈Yes

指紋

varespladib methyl
Stents
Metals
Ankle Brachial Index
Amputation
Safety
Mortality

ASJC Scopus subject areas

  • Medicine(all)

引用此文

Covered stent versus bare-metal stents for chronic total occluded long complicated femoropopliteal lesions : A 2-year single center review. / Lin, Ting Chao; Chen, Po Lin; Lee, Chiu Yang; Shih, Chun Che; Chen, I. Ming.

於: Journal of the Chinese Medical Association : JCMA, 卷 82, 編號 1, 01.01.2019, p. 44-49.

研究成果: 雜誌貢獻文章

@article{1004248812df4f3187e3e543346c9751,
title = "Covered stent versus bare-metal stents for chronic total occluded long complicated femoropopliteal lesions: A 2-year single center review",
abstract = "BACKGROUND: To compare the efficacy, safety, and results of Viabahn versus bare-metal stents (BMS) in chronic total occluded (CTO) long femoropopliteal lesions. METHODS: From April 2009 to August 2014, a total 97 patients (71.2 ± 9.7, 45-90 years old, 70 males) with occluded femo-ropopliteal lesions underwent Viabahn (55 patients) or BMS (42 patients) implantation. The clinical findings, procedural factors, and overall outcomes were collected and analyzed. RESULTS: The average lesion length was 22.1 ± 4.8 cm in the Viabahn group and 17.8 ± 3.3 cm in the BMS group. Both groups had a 100{\%} technical success rate. Although there was no difference between the groups in complication, mortality, and major amputation rates, the Viabahn group had a significantly better average post-operative ankle brachial index (ABI) at 1-year and 2-year follow-ups. The Viabahn group also had significantly less in-stent restenosis (ISR) and target lesion revascularization (TLR) compared with the BMS group. Nevertheless, the two groups shared similar 2-year primary patency rates (63.6{\%} vs. 50.0{\%}, p = .178) and 2-year secondary patency rates (85.5{\%} vs. 81.0{\%}, p = .554). CONCLUSION: Both Viabahn and BMS were efficient treatments for long femoropopliteal CTO lesions. However, the Viabahn group had significantly improved results compared with the BMS group in TLR and ISR, but the difference was not sufficient enough to result in different primary and secondary patency rates.",
author = "Lin, {Ting Chao} and Chen, {Po Lin} and Lee, {Chiu Yang} and Shih, {Chun Che} and Chen, {I. Ming}",
year = "2019",
month = "1",
day = "1",
doi = "10.1097/JCMA.0000000000000005",
language = "English",
volume = "82",
pages = "44--49",
journal = "Journal of the Chinese Medical Association",
issn = "1726-4901",
publisher = "Elsevier Taiwan LLC",
number = "1",

}

TY - JOUR

T1 - Covered stent versus bare-metal stents for chronic total occluded long complicated femoropopliteal lesions

T2 - A 2-year single center review

AU - Lin, Ting Chao

AU - Chen, Po Lin

AU - Lee, Chiu Yang

AU - Shih, Chun Che

AU - Chen, I. Ming

PY - 2019/1/1

Y1 - 2019/1/1

N2 - BACKGROUND: To compare the efficacy, safety, and results of Viabahn versus bare-metal stents (BMS) in chronic total occluded (CTO) long femoropopliteal lesions. METHODS: From April 2009 to August 2014, a total 97 patients (71.2 ± 9.7, 45-90 years old, 70 males) with occluded femo-ropopliteal lesions underwent Viabahn (55 patients) or BMS (42 patients) implantation. The clinical findings, procedural factors, and overall outcomes were collected and analyzed. RESULTS: The average lesion length was 22.1 ± 4.8 cm in the Viabahn group and 17.8 ± 3.3 cm in the BMS group. Both groups had a 100% technical success rate. Although there was no difference between the groups in complication, mortality, and major amputation rates, the Viabahn group had a significantly better average post-operative ankle brachial index (ABI) at 1-year and 2-year follow-ups. The Viabahn group also had significantly less in-stent restenosis (ISR) and target lesion revascularization (TLR) compared with the BMS group. Nevertheless, the two groups shared similar 2-year primary patency rates (63.6% vs. 50.0%, p = .178) and 2-year secondary patency rates (85.5% vs. 81.0%, p = .554). CONCLUSION: Both Viabahn and BMS were efficient treatments for long femoropopliteal CTO lesions. However, the Viabahn group had significantly improved results compared with the BMS group in TLR and ISR, but the difference was not sufficient enough to result in different primary and secondary patency rates.

AB - BACKGROUND: To compare the efficacy, safety, and results of Viabahn versus bare-metal stents (BMS) in chronic total occluded (CTO) long femoropopliteal lesions. METHODS: From April 2009 to August 2014, a total 97 patients (71.2 ± 9.7, 45-90 years old, 70 males) with occluded femo-ropopliteal lesions underwent Viabahn (55 patients) or BMS (42 patients) implantation. The clinical findings, procedural factors, and overall outcomes were collected and analyzed. RESULTS: The average lesion length was 22.1 ± 4.8 cm in the Viabahn group and 17.8 ± 3.3 cm in the BMS group. Both groups had a 100% technical success rate. Although there was no difference between the groups in complication, mortality, and major amputation rates, the Viabahn group had a significantly better average post-operative ankle brachial index (ABI) at 1-year and 2-year follow-ups. The Viabahn group also had significantly less in-stent restenosis (ISR) and target lesion revascularization (TLR) compared with the BMS group. Nevertheless, the two groups shared similar 2-year primary patency rates (63.6% vs. 50.0%, p = .178) and 2-year secondary patency rates (85.5% vs. 81.0%, p = .554). CONCLUSION: Both Viabahn and BMS were efficient treatments for long femoropopliteal CTO lesions. However, the Viabahn group had significantly improved results compared with the BMS group in TLR and ISR, but the difference was not sufficient enough to result in different primary and secondary patency rates.

UR - http://www.scopus.com/inward/record.url?scp=85062606783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062606783&partnerID=8YFLogxK

U2 - 10.1097/JCMA.0000000000000005

DO - 10.1097/JCMA.0000000000000005

M3 - Article

C2 - 30839403

AN - SCOPUS:85062606783

VL - 82

SP - 44

EP - 49

JO - Journal of the Chinese Medical Association

JF - Journal of the Chinese Medical Association

SN - 1726-4901

IS - 1

ER -